Name: Can the principles of effective prevention withstand the counterwinds of commercialization?
Uploaded: 2021-09-10T19:19:08+00:00
Duration: 59 min 12 s
Description: Prevention is possible! Can the principles of effective prevention withstand the counterwinds of commercialization? Featured expert: Catherine Antley, M.D. ORIGINAL WEBINAR: FRIDAY, September 10, 2021

4 years ago

112

Prevention is possible! Can the principles of effective prevention withstand the counterwinds of commercialization?

Featured expert: Catherine Antley, M.D.

ORIGINAL WEBINAR: FRIDAY, September 10, 2021

Handouts available at https://johnnysambassadors.org/ja210910/

Description 
Do most Americans realize that treatment for substance use disorder is the least effective, most expensive method to deal with a societal substance misuse epidemic (now impacting approximately 1 in 3 American families)?

Learning Objectives
1. Learn the principles of effective prevention and become familiar with their proven track record.
2. Briefly consider the cost and effectiveness of prevention vs treatment.
3. Understand the vulnerability of the youth brain, impact of concentration.
4. Understand scientists have demonstrated that youth are products of their environment and that scientists have demonstrated that by changing children’s environment we can either release their minds allowing for full development or limit them by facilitating the creation of a use disorder.
5. Understand how without effective public health guardrails, the drivers of commercialization of addictive substances run counter to the principles of effective prevention

Speaker Bio
 Catherine Antley, M.D. graduated from the University of North Carolina School of Medicine, completed her residency in anatomic and clinical pathology at Duke University Medical Center and fellowship in dermatopathology at the University of Arkansas for Medical Sciences. She is board certified in Anatomic and Clinical Pathology and in Dermatopathology and is a Fellow of the American Society of Dermatopathology. For 20 years she has served as Laboratory Director of Vermont Dermatopathology, a woman owned, independent dermatopathology lab serving VT, NY, and NH. She has a strong interest in public health and prevention and exploring the impact of policy on addiction and health care costs. She has co-authored a number of Vermont Medical Society resolutions on cannabis and recently organized and led a delegation of 10 Vermonters to Iceland to learn about their 20-year history bringing down the country’s high addiction rates using their successful, science-based prevention model. She recently contributed chapter 15″Cannabis in Dermatology” to the textbook “Cannabis in Medicine, an Evidence Based Approach” edited by Dr. Ken Finn and published by Springer Nature. She serves as Secretary Treasurer of the International Academy on the Science and Impact of Cannabis.

Questions?
Email Founder & CEO, Laura Stack, at [email protected]